<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200825048515N17</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-12-24</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of two methods "ulnar nerve decompression with transposition" and "ulnar nerve decompression alone" in improving patients with cubital tunnel syndrome</public_title>
      <acronym></acronym>
      <scientific_title>Comparative evaluation of the therapeutic results of two methods of ulnar nerve decompression with transposition and ulnar nerve decompression alone in patients with cubital tunnel syndrome</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-12-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52840</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: In this study, due to the different use of the two surgical methods, the orthopedic assistant is aware of the type of intervention. But the patient, data collector, and data analyst will not know of the type of patient grouping.</study_design>
      <phase>3</phase>
      <hc_freetext>Cubital Tunnel Syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: In this group, the patient is located in a supine position, and after closing the tourniquet or Esmarch bandage, and prepping and draping the upper part of the limb. 15 cm skin cutting begins from about 5-6 cm from distal to the posterior medial epicondyle and continues to 10 cm from proximal to the medial epicondyle. After cutting the skin and opening the skin and subcutaneous tissue and protecting the antebrachial cutaneous nerve, the ulnar nerve is explored (posterior to medial intermuscular septum and anterior to the interior head of the triceps). Pressure points on the nerve are released along this path, the arcade of the structure is removed, and the ulnar nerve feeding vessels are retained as long as possible. The ulnar nerve is released and after examination for the absence of pathological lesions and adhesion of the wound, it is washed and repaired skin and under the skin and the dressing and bandage are done by bandaging from the palm crease to the top of the arm. Intervention 2: Intervention group 2: In this group, the patient is located in a supine position and after closing the tourniquet or Esmarch bandage, and prepping and draping the upper part of the limb. 15 cm skin cutting begins from about 5-6 cm from distal to the posterior medial epicondyle and continues to 10 cm from proximal to the medial epicondyle. After cutting the skin and opening the skin and subcutaneous tissue and protecting the antebrachial cutaneous nerve, the ulnar nerve is explored (posterior to medial intermuscular septum and anterior to the interior head of the triceps). Pressure points on the nerve are released along this path, the arcade of struther is removed, and the ulnar nerve feeding vessels are retained as long as possible. The ulnar nerve is released and after examination for the absence of pathological lesions and adhesion of the wound, it is washed and repaired skin and under the skin and the dressing and bandage is done by bandaging from the palm crease to the top of the arm.The ulnar nerve after the release of the abovementioned path, the entrance to the forearm by keeping the branches of the nerve to the flexor carpi ulnaris muscle and no damage to them is passed to the anterior flexor-pronator mass and under a tab of flexor and pronator group fascia, which is about 1.5 inches long and 1.5 inches wide, is placed and the tab base is in the medial direction and its lateral edge is exposed to the subcutaneous tissue. After transposition and opening of the tourniquet, homeostasis is performed well. The hemovac drain is placed, the skin and under the skin are sewn, and the dressing and bandage are applied with a bandage from the palm crease to the top of the arm.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Abolghasem Zarezadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Orthopedic Department, Al-Zahra Hospital, Sefeh Blvd., Tohid Street</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174675731</zip>
        <telephone>+98 31 3620 2020</telephone>
        <email>Rashed_petro@yahoo.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Abolghasem Zarezadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Orthopedic Department, Al-Zahra Hospital, Sefeh Blvd., Tohid Street</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174675731</zip>
        <telephone>+98 31 3620 2020</telephone>
        <email>Rashed_petro@yahoo.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of cubital syndrome by electromyography and nerve conduction velocity(EMG-NCV)
Failure to respond to non-surgical treatments performed so far
Satisfaction to participate in the study</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of hand surgery
History of trauma penetrating the nerves of the hand
History of cervical neurosurgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G56.20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Lesion of ulnar nerve, unspecified upper limb</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: In this group, the patient is located in a supine position, and after closing the tourniquet or Esmarch bandage, and prepping and draping the upper part of the limb. 15 cm skin cutting begins from about 5-6 cm from distal to the posterior medial epicondyle and continues to 10 cm from proximal to the medial epicondyle. After cutting the skin and opening the skin and subcutaneous tissue and protecting the antebrachial cutaneous nerve, the ulnar nerve is explored (posterior to medial intermuscular septum and anterior to the interior head of the triceps). Pressure points on the nerve are released along this path, the arcade of the structure is removed, and the ulnar nerve feeding vessels are retained as long as possible. The ulnar nerve is released and after examination for the absence of pathological lesions and adhesion of the wound, it is washed and repaired skin and under the skin and the dressing and bandage are done by bandaging from the palm crease to the top of the arm.</i_keyword>
      <i_keyword>Intervention group 2: In this group, the patient is located in a supine position and after closing the tourniquet or Esmarch bandage, and prepping and draping the upper part of the limb. 15 cm skin cutting begins from about 5-6 cm from distal to the posterior medial epicondyle and continues to 10 cm from proximal to the medial epicondyle. After cutting the skin and opening the skin and subcutaneous tissue and protecting the antebrachial cutaneous nerve, the ulnar nerve is explored (posterior to medial intermuscular septum and anterior to the interior head of the triceps). Pressure points on the nerve are released along this path, the arcade of struther is removed, and the ulnar nerve feeding vessels are retained as long as possible. The ulnar nerve is released and after examination for the absence of pathological lesions and adhesion of the wound, it is washed and repaired skin and under the skin and the dressing and bandage is done by bandaging from the palm crease to the top of the arm.The ulnar nerve after the release of the abovementioned path, the entrance to the forearm by keeping the branches of the nerve to the flexor carpi ulnaris muscle and no damage to them is passed to the anterior flexor-pronator mass and under a tab of flexor and pronator group fascia, which is about 1.5 inches long and 1.5 inches wide, is placed and the tab base is in the medial direction and its lateral edge is exposed to the subcutaneous tissue. After transposition and opening of the tourniquet, homeostasis is performed well. The hemovac drain is placed, the skin and under the skin are sewn, and the dressing and bandage are applied with a bandage from the palm crease to the top of the arm.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Symptom improvement score. Timepoint: One month, three months, six months and one year after the intervention. Method of measurement: Modified Bishop rating system.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Isfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-12-05</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Street address Isfahan University of Medical Sciences, Hezar Jarib Ave., Azadi Sq Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
